Condition: Chronic Hepatitis B · Nonalcoholic Fatty Liver Disease · Sponsor: Humanity and Health Research Centre
The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).
This description comes directly from the study's public registry record.
George Lau, MD · +852 2861 3777 · gkklau@netvigator.com
Always discuss trial participation with your own doctor first.
| Humanity and Health GI and Liver Centre | Hong Kong, Hong Kong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02863757